HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) sold 0.1% of their position (64.00 shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $1.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/19/2025ACC: 0001193125-25-209387
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-64.00
Net shares
Net seller
$1.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
64.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−64.00
Price / share
$29.17
Trade value
$1.87K
% of position
0.1%
9/18/2025
50.31K→50.24K
Total
Net shares
−64.00
Net value
-$1.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/18/2025 | S · Sale | −64.00 | $29.17 | $1.87K | 0.1% | 50.31K | 50.24K |
| Total | −64.00 | -$1.87K | ||||||
Derivative Transactions0
No derivative transactions reported